Gene Therapy Sponsors Risk Additional Work With Late-Stage Manufacturing Changes

pharmaceutical manufacturing
An OTP official said pre-IND teleconference requests may be converted to written response only because of the agency's growing workload in the space. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies